ALEXSA Standardization for Clinical Use
ALEXSA 临床应用标准化
基本信息
- 批准号:8536779
- 负责人:
- 金额:$ 42.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-03-01 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:12 year old13 year oldAccountingAgeAlcohol or Other Drugs useAlcoholsAttention deficit hyperactivity disorderBehaviorBooksBusinessesCensusesCharacteristicsChildChild CareChildhoodChronicCigaretteClinicalClinical PsychologyClinical assessmentsCognitiveComputer AssistedComputer softwareComputersConduct DisorderConfidentialityDataData Storage and RetrievalDevelopmentDevicesDiagnosisDisabled PersonsEarly DiagnosisEarly InterventionEducationElectronicsEmotionalEpidemiologyEvaluationExposure toFundingFutureGenderGeneral PopulationGoalsGuidelinesHealth ProfessionalHealthcareIndividualInstitutesInternationalInterventionInterviewK-Series Research Career ProgramsManualsMarketingMeasuresMethodsMinorMissionModelingMonitorMovementNational Institute of Drug AbusePaperPatientsPerformancePharmaceutical PreparationsPhasePreparationPrevalencePreventionPrevention programPrimary Care PhysicianProblem behaviorPropertyPsychological TestsPsychologistPsychometricsPublishingReadingRecordsReportingResearchRiskRisk FactorsSchool-Age PopulationSchoolsServicesSmall Business Technology Transfer ResearchSocioeconomic StatusSpecial EducationStandardizationStudentsSubstance Use DisorderSystemTestingWorkWritingYouthadolescent substance useanti socialbasebehavioral healthbrief screeningcheckup examinationcommercializationcomputerizedcostdisorder preventiondisorder riskelementary schoolevidence baseflexibilityhandicapping conditionhigh riskhigh schoolilliterateimprovedinnovationinstrumentlaptopmeetingsnovelportabilitypreventpublic health relevancereduced substance useresponsescreeningskillstool
项目摘要
DESCRIPTION (provided by applicant): This STTR Phase II application is to finalize the one-of-its-kind Assessment of Liability and Exposure to Substance use and antisocial behavior(c) (ALEXSA(c)) for educator, pediatric, prevention and epidemiology uses. The ALEXSA system, first funded by a NIDA K-Award, acquires child-report (8- to 13-year-olds) data using an illustrated, computer format that is enjoyable and can be completed by illiterate youth. Nine risk domains (factor scores) and over 40 risk factor subscales canbeusedtomeasure liability to, and early forms of, problematic substance use (SU) and chronic behavior problems. The ALEXSA can be administered by child care professionals to groups of children or individuals. It is unique among child-report assessments in developmental appropriateness, breadth of characteristics measured, flexibility for tailored assessment, user-friendliness, and utility for research and intervention. The ALEXSA offers customers a format perceived by youth to have greater confidentiality than paper forms, automated data storage, and scores immediately upon completion (e.g., for screening and referral to intervention). Among ALEXSA's psychometric properties is a brief screen with an overall 85% predictive accuracy of SU one-year later among high-risk youth younger than 12 years old. This screen thus detects youth at high risk for substance use disorder long before its onset providing long-term opportunity for prevention. Phase I work developed a highly portable net book version and a PDA screen version of the ALEXSA. Phase II efforts will refine the ALEXSA using sophisticated methods and an extensive evaluation to enable in-depth clinical assessment of individuals (akin to IQ tests). ALEXSA scoring will be standardized to the U.S. general population. ALEXSA system products will be tailored to the needs of specific professions based on expert reviews. User's Manuals will be created. All products will be refined to be publish-quality. Collectively, this augmentation of the
innovative ALEXSA research instrument into a tool that provides state-of-the-art assessment will assist professionalism meeting mandates for 6 million annual early intervention services and SU/SUD risk screenings by over 93,000 behavioral health professionals, over 150,000 primary care physicians and 41,000 school psychologists. The ALEXSA's innovative features, broad and evidence-based subscales and scores, and psychometric properties will permit it to fill gaps in several large niche markets and create barriers to potential competitors.
描述(由申请人提供):此STTR II阶段的应用是为了完成对教育,儿科,预防和流行病学用途的责任和暴露于药物使用和反社会行为(C)(Alexsa(c))的一种独一无二的评估。最初由NIDA K-award资助的Alexsa系统使用插图的计算机格式获得了儿童报告(8至13岁)的数据,该数据非常愉快,可以由文盲青年完成。九个风险域(因子得分)和40多个风险因素子量表可能对有问题的药物使用(SU)和慢性行为问题承担责任和早期形式。 Alexsa可以由托儿专业人员管理给儿童或个人群体。在儿童报告评估中,它在发育适当性,测量特征的广度,量身定制评估的灵活性,用户友好性以及用于研究和干预的实用性中是独一无二的。 Alexsa为客户提供了一种被青年人所感知的格式,其机密性比纸质表格,自动数据存储以及完成后立即得分(例如,筛查和转介到干预措施)。在Alexsa的心理测量特性中,有一个简短的屏幕,在12岁以下的高风险青年中,SU的总体预测准确性为85%。因此,该屏幕在很久以前就检测到有药物使用障碍的高风险的年轻人为预防预防的长期机会。第一阶段的工作开发了高度便携式的网书版本和Alexsa的PDA屏幕版本。第二阶段的努力将使用复杂的方法和广泛的评估来完善Alexsa,以实现对个体的深入临床评估(类似于智商测试)。 Alexsa评分将标准化为美国普通人群。 Alexsa System产品将根据专家审查的特定专业需求量身定制。将创建用户手册。所有产品将被完善为发布质量。总体而言,这种增强
创新的Alexsa研究工具纳入提供最先进的评估的工具,将有助于遵守93,000多名行为卫生专业人员,超过150,000名初级保健医生和41,000名学校心理学家的600万次年度早期干预服务和SU/SUD风险筛查的专业授权。 Alexsa的创新特征,广泛的基于证据的子量表和分数以及心理计量学特性将使其能够填补几个大型利基市场的空白,并为潜在的竞争对手造成障碍。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TY A RIDENOUR其他文献
TY A RIDENOUR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TY A RIDENOUR', 18)}}的其他基金
DRUG USE LIABILITY: INVESTIGATING COMPETING MODELS
药物使用责任:研究竞争模型
- 批准号:
6617787 - 财政年份:2000
- 资助金额:
$ 42.06万 - 项目类别:
DRUG USE LIABILITY: INVESTIGATING COMPETING MODELS
药物使用责任:研究竞争模型
- 批准号:
6130467 - 财政年份:2000
- 资助金额:
$ 42.06万 - 项目类别:
DRUG USE LIABILITY: INVESTIGATING COMPETING MODELS
药物使用责任:研究竞争模型
- 批准号:
6780959 - 财政年份:2000
- 资助金额:
$ 42.06万 - 项目类别:
DRUG USE LIABILITY: INVESTIGATING COMPETING MODELS
药物使用责任:研究竞争模型
- 批准号:
6378313 - 财政年份:2000
- 资助金额:
$ 42.06万 - 项目类别:
DRUG USE LIABILITY: INVESTIGATING COMPETING MODELS
药物使用责任:研究竞争模型
- 批准号:
6693429 - 财政年份:2000
- 资助金额:
$ 42.06万 - 项目类别:
相似国自然基金
13-17岁青少年脊柱关节突关节的数字化三维形态发育研究
- 批准号:81560348
- 批准年份:2015
- 资助金额:38.0 万元
- 项目类别:地区科学基金项目
相似海外基金
General Brain Arousal and Risk for Eating Disorder
一般大脑唤醒和饮食失调的风险
- 批准号:
10365378 - 财政年份:2021
- 资助金额:
$ 42.06万 - 项目类别:
General Brain Arousal and Risk for Eating Disorder
一般大脑唤醒和饮食失调的风险
- 批准号:
10656518 - 财政年份:2021
- 资助金额:
$ 42.06万 - 项目类别: